Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b StudyYuankai Shi, Tingting Song, Zhijie Pan et al.|Journal of Thoracic Oncology|2022Cited by 29
Safety, efficacy and pharmacokinetics of BPI-9016M in c-MET overexpression or MET exon 14 skipping mutation patients with locally advanced or metastatic non-small-cell lung cancer: a phase Ib studyXingsheng Hu, Yuankai Shi, Xinge Cui et al.|BMC Cancer|2023Cited by 8